These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4716182)

  • 1. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
    Hsiao YY; Bardos TJ
    J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkylating analogues of the tumour inhibitor 5-aziridino-2,4-dinitrobenzamide.
    Tisdale MJ
    Chem Biol Interact; 1971 Apr; 3(2):95-107. PubMed ID: 5156644
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkylating agents related to 2,2'-biaziridine. 3. The stereoisomeric N,N'-dimethanesulfonyl-2,2'-biaziridines.
    Feit PW; Nielsen OT
    J Med Chem; 1970 May; 13(3):447-52. PubMed ID: 5460301
    [No Abstract]   [Full Text] [Related]  

  • 4. Alkylating agents related to 2,2'-biaziridine. II. N,N'-dicarbethoxy-2,2'-biaziridine.
    Feit PW; Nielsen OT
    J Med Chem; 1967 Sep; 10(5):927-32. PubMed ID: 6048504
    [No Abstract]   [Full Text] [Related]  

  • 5. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
    Noell CW; Cheng CC
    J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
    Hsiao YY; Bardos TJ; Wampler GL; Regelson W
    J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity correlations of anticancer agents: diaminopyrimidines, N-acyltriamines, bis-(1-aziridinyl)-phosphinyl carbamates, and aromatic nitrogen mustards.
    Lien EJ; Tong GL
    Cancer Chemother Rep; 1973; 57(3):251-61. PubMed ID: 4796118
    [No Abstract]   [Full Text] [Related]  

  • 11. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS IV. EFFECT OF RING SUBSTITUENTS ON THE ALKYLATING AND HYDROLYTIC PROPERTIES OF BIS-(1-AZIRIDINYL)PHOSPHINYL CARBAMATES.
    BARDOS TJ; CHMIELEWICZ ZF; NAVADA CK
    J Pharm Sci; 1965 Mar; 54():399-403. PubMed ID: 14302149
    [No Abstract]   [Full Text] [Related]  

  • 12. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
    van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
    J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the cytostatic effect of new synthetic carbamoyl esters "in vivo". 1].
    Demetrescu C; Gheorghiu P; Görk E; Chirită C; Mavrodin A; Teitel A
    Pharmazie; 1965 Oct; 20(10):634-6. PubMed ID: 5880091
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential bioreductive alkylating agents. 3. Synthesis and antineoplastic activity of acetoxymethyl and corresponding ethyl carbamate derivatives of benzoquinones.
    Lin AJ; Shansky CW; Sartorelli AC
    J Med Chem; 1974 May; 17(5):558-61. PubMed ID: 4830263
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of three aziridine alkylating compounds on the gross development of chicken embryos.
    Younger RL
    Toxicol Appl Pharmacol; 1973 Mar; 24(3):423-33. PubMed ID: 4122266
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative aspects of the relationship of the antitumor activity and toxicity of diaziridinyl-sym. triazines to their physicochemical properties].
    Ivin BA; Filov VA; Kraĭz BO; Belogorodskiĭ VV; Maliugina LL
    Vopr Onkol; 1979; 25(7):71-5. PubMed ID: 483685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
    J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour-growth inhibitory nitrophenylaziridines and related compounds: structure-activity relationships. II.
    Khan AH; Ross WC
    Chem Biol Interact; 1971 Dec; 4(1):11-22. PubMed ID: 5156332
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
    MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
    J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.